Latest Funding News

Phoslock Environmental Technologies reported a widening cashflow deficit and disappointing sales in the December 2024 quarter, while legal challenges and share suspension continue to cloud its outlook.

Patagonia Lithium has withdrawn its previously announced 15-year, 10,000 tonnes per annum production target, clarifying it was aspirational and not compliant with ASX Listing Rules. This retraction raises questions about the project's near-term viability and investor confidence.

Caspin Resources has completed its acquisition of the Bygoo Tin Project in NSW and is set to begin a significant drilling campaign, backed by a recent $1.6 million capital raise.

Ten Sixty Four Limited has received a crucial US$10.5 million payment from Philsaga Mining Corporation, enabling it to settle outstanding related party debts and advance its Deed of Company Arrangement.

Arafura Rare Earths Limited has acknowledged a breach of ASX Listing Rule 15.7 following premature media disclosure of a $200 million investment commitment from the National Reconstruction Fund Corporation. The company outlines corrective steps to prevent future compliance lapses.

Alterity Therapeutics is poised to release topline data from its pivotal ATH434-201 Phase 2 trial in early-stage Multiple System Atrophy by February 2025, while managing a cash balance of A$4.54 million amid ongoing research expenses.

Pacgold Limited reports promising high-grade gold anomalies from a major aircore drilling campaign at its Alice River Gold Project, alongside strategic board appointments and a successful Share Purchase Plan to fuel further exploration.

Metrics Real Estate Multi-Strategy Fund has announced an estimated ordinary dividend of AUD 0.0096 per security, with key dates set for late January and early February 2025. The dividend is unfranked and relates to the financial period ending January 31, 2025.

Clime Investment Management has reported a return to profitability in the December half, proposing an interim dividend and unveiling strategic initiatives to drive future growth.

VanEck Investments Limited has outlined the dividend timetable for its suite of Australian and global bond ETFs, providing investors with critical dates for dividend entitlements and reinvestment options.

Income Asset Management delivered steady revenue of $4.0 million in Q2 FY2025 alongside significant growth in funds under administration and client accounts, while retiring $10 million in debt to reduce interest costs.

BOD Science has executed an asset sale deed transferring critical intellectual property rights to Optimus Salvus, marking a pivotal step in its Deed of Company Arrangement process.